A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. - Wikidata - awgldk - TriplyDB

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

http://www.wikidata.org/entity/Q34763502

about

Advances of gene therapy for primary immunodeficiencies Clinical development of gene therapy: results and lessons from recent successes Recent advances in treatment of severe primary immunodeficiencies Gene therapy: progress and predictions Multifunctional facets of retrovirus integrase Neuroanatomy goes viral!Gene therapy studies in a canine model of X-linked severe combined immunodeficiency Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies Advantages and applications of CAR-expressing natural killer cells Human RAG mutations: biochemistry and clinical implications Retroviral DNA Integration Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.Use of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.Gene Therapy 2017: Progress and Future Directions.Clinical applications of gene therapy for primary immunodeficiencies.History and current status of newborn screening for severe combined immunodeficiency.Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor.Simple viral/minimal piggyBac hybrid vectors for stable production of self-inactivating gamma-retroviruses.INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells Progress and challenges in viral vector manufacturing From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.Sites of retroviral DNA integration: From basic research to clinical applications Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.Gene therapy for primary immune deficiencies: a Canadian perspective.Severe combined immunodeficiency: recent developments and guidance on clinical management.Gene therapy for primary immunodeficiencies.Gene therapy for monogenic disorders of the bone marrow.Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.BTK Signaling in B Cell Differentiation and Autoimmunity.Reconstructing the immune system with lentiviral vectors.Gene therapy research in Asia.Function and safety of lentivirus-mediated gene transfer for CSF2RA-deficiency.The functional relationship between hematopoietic stem cells and developing T lymphocytes.Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy.Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future.Reliable RT-qPCR-based titration of retroviral and lentiviral vectors via quantification of residual vector plasmid DNA in samples.Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.

P2860

Q26742031-AEF5B411-D52D-4A6F-AA50-AD62CF6A4799 Q26743393-43A586AA-7217-42D8-B879-7334B409F960 Q26766170-5788347C-88E6-4354-A64E-66F08310D813 Q26772109-0B68EDC3-14EA-4285-B20E-2C5F2C2C6671 Q26795766-758F3C47-136F-4079-93C2-5E52673E3007 Q26802140-6BF32639-8D81-4DB4-84CE-78C6D463CE39 Q27026069-79E61D1F-3229-40F2-902C-4B6DD31C4732 Q28076919-1AA05633-D5C7-45D7-8557-F879F1114917 Q28080875-557EEE3D-1839-4706-9E07-6D1957B2A11F Q28274274-1657D873-C22B-4FD2-B312-0187DDCD3574 Q28596842-A76B05FC-B794-45B9-A125-CE5D96E0E6B3 Q30364488-ADDEA8ED-44B9-4035-B84F-FC2EE9712F02 Q33427651-44F4967E-A5D5-4961-AF28-B16972627DA1 Q33586182-D3B2D110-6E5D-4830-8B1A-8DDA5A11C44C Q33671980-9E6EA654-C66A-4F17-B113-8E2E0219DC3E Q33891559-577F9ACB-F133-4A00-980C-441B24DC5B4B Q35539617-B60A12C9-86A7-4DE4-B7EE-A47D3CE50691 Q35613205-C7F2FA5C-3E06-43AD-A94E-2D077926AC7F Q35751032-DC3833FA-1053-49A4-8F5A-0C833478A077 Q35755162-485DA2F2-AF3B-4F18-8B17-3677CEAF6032 Q36323403-AC26CCCD-1831-4AAC-BEAB-F554D039093F Q36675323-13C10A6A-5DD2-4D9E-8A0A-EE6A43E26602 Q36713761-42805738-9FD5-4A2A-99F8-3A4582609CEC Q36756725-1A0E251E-B5B4-44BB-B15F-30C478859466 Q36900663-D46A5F45-A339-4503-A58B-BF8B47613D1F Q37089728-E348ACF5-EE66-416A-AABC-7255FDE3B006 Q37668317-D107DDD7-D543-41C3-819B-FCAC448C2157 Q38309572-3B8A1269-4B01-446A-BB10-7F9B1F566912 Q38364511-564F97FF-DF58-41FB-8D1B-D20C87512209 Q38516548-6BA2D140-7CC9-4CE8-9371-F9B3E7A5B749 Q38519892-9786CEA3-CFAA-4ED3-B50B-625D000BB645 Q38581000-5DD9FF4B-91B7-44E7-8E8C-FECDEB27B568 Q38651711-69B8F1E4-3740-4818-B0BB-57DF91EECEF0 Q38654544-D9FD73BB-F052-48EC-9CB5-ADBEE6C07BB1 Q38693783-6021ACFA-4FB3-4947-9ACB-CF152019CCCF Q38698470-12F0F362-1C79-4194-8052-9313A24047BF Q38729963-B1AEE670-3535-4D62-99CB-10C362708609 Q38735833-47F8F572-1346-493D-86E4-487761A44841 Q38773166-1481ACF8-3A46-482F-AF10-396B857540C1 Q38788187-16415494-64CB-4035-B8DD-FEFBE8728DDD

P2860

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

http://www.wikidata.org/entity/Q34763502

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@ast

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@en

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@nl

type

label

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@ast

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@en

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@nl

prefLabel

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@ast

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@en

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@nl

P1433

Q34763502-60EB415E-A7A4-49E5-BAB5-B5C0AEC8941C

P1476

Q34763502-FFFA5A7B-9DF7-4B83-A18E-63395EC9FD2F

P2093

Q34763502-03EEA881-0873-4F79-9C17-06C24EEEFF59

Q34763502-06475979-C787-4417-AD45-C17B9205E86F

Q34763502-0C084804-10D4-483A-8024-2D769B13DF76

Q34763502-1035CF93-213B-4539-881B-01E044048734

Q34763502-1516A310-1712-438D-B4E5-FBA3CB80282B

Q34763502-196D89D7-D620-48C3-A6D3-3FE244F2B0FF

Q34763502-1C1EACC8-7875-448F-B621-B261D8A4458F

Q34763502-1E8ACC70-B5C3-4B7B-88EB-41FA4562EBE8

Q34763502-20F2B358-B00C-4ECF-B205-C3BABEC7F039

Q34763502-271CBF6C-80EB-4820-8FBB-0CAB09FA5240

P2860

Q34763502-0D159E3F-FBDB-4AAE-B9CD-E6B521C33F9E

Q34763502-1DF07F61-AC05-4A52-902E-06F48792359D

Q34763502-1FD75280-214B-4FD9-9E4A-DF57C1C999C7

Q34763502-23884E83-40ED-4348-89D7-798DDCE27B94

Q34763502-27E11F8C-3921-4026-96A6-EAA06549783D

Q34763502-2821C05C-5042-4071-87DD-A1775F902C04

Q34763502-28CB26FE-AB22-46DF-84B6-65225070E009

Q34763502-34CACDA2-4868-4213-AA77-F228255659B5

Q34763502-381E9DA2-47BB-431E-9BD7-AD9A6942E9C4

Q34763502-3CE6459A-EFA6-49A1-AD5E-D27B7AF24E43

P304

Q34763502-758266A8-EE46-47B0-ACE3-0F84A1FFFA01

P31

Q34763502-153646A4-8E40-44DF-B012-56027416784E

P356

Q34763502-8478D852-8CB6-45D5-8B72-E457BC8461D4

P407

Q34763502-7D06D058-4A87-434A-B774-77F455672D2E

P433

Q34763502-351C9F4D-75AE-4C44-8353-45247BEF921B

P478

Q34763502-F0124217-7C8E-4DE1-8BFE-E1579A706C23

P50

Q34763502-001A1189-80DA-4CE3-925C-56C0FC0275F3

Q34763502-066B8402-7926-4762-8E40-73048CCCCF20

Q34763502-0C6EB0FE-C1F0-4454-A543-F10EA505CD77

Q34763502-122D49CA-835F-4FA0-BA9A-DBC3D059B353

Q34763502-40CD882A-3304-4197-AF1B-555FB4652ABC

Q34763502-4FFB9363-088B-4AA5-9677-B18039D98024

Q34763502-5544D86F-0BC2-480A-8295-790219CE8FE1

Q34763502-77DDFE23-1312-4045-AE33-F5F27CA5C10F

Q34763502-A5BEB433-E3A6-46CE-95EE-092F2B587E86

Q34763502-A9F15CF2-DF80-44FD-B730-AE9D08B21ABE

P577

Q34763502-AB7B9CA5-A455-4D47-B9DB-C6EB4A88C041

P698

Q34763502-E6FAF783-BB4D-424C-BA54-C444B70413E8

P932

Q34763502-3018DC67-79C9-4B5E-8281-B69C6142A48E

P356

P1433

The New England Journal of Medicine

P1476

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

@en

P2093

Alexandra H Filipovich

http://www.w3.org/2001/XMLSchema#string

Alla Tsytsykova

http://www.w3.org/2001/XMLSchema#string

Anne-Marie McNicol

http://www.w3.org/2001/XMLSchema#string

Annick Lim

http://www.w3.org/2001/XMLSchema#string

Benedicte Neven

http://www.w3.org/2001/XMLSchema#string

Chad E Harris

http://www.w3.org/2001/XMLSchema#string

Charles C Berry

http://www.w3.org/2001/XMLSchema#string

Christine Rivat

http://www.w3.org/2001/XMLSchema#string

Christopher Baum

http://www.w3.org/2001/XMLSchema#string

David A Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Efficacy of gene therapy for X-linked severe combined immunodeficiency

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Selection of target sites for mobile DNA integration in the human genome

Comparing DNA integration site clusters with scan statistics.

Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial

Estimating abundances of retroviral insertion sites from DNA fragment length data.

P304

1407-1417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1404588

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P50

Marina Cavazzana-Calvo

Despina Moshous

Capucine Picard

Salima Hacein-Bey-Abina

Emmanuelle M. Six

Laure Caccavelli

Satiro N De Oliveira

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25295500

http://www.w3.org/2001/XMLSchema#string

P932

4274995

http://www.w3.org/2001/XMLSchema#string